BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16519569)

  • 1. Gliosarcoma with liposarcomatous differentiation: the new member of the lipid-containing brain tumors family.
    Vlodavsky E; Konstantinesku M; Soustiel JF
    Arch Pathol Lab Med; 2006 Mar; 130(3):381-4. PubMed ID: 16519569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of gliosarcoma with liposarcomatous differentiation.
    Fukuda T; Yasumichi K; Suzuki T
    Pathol Int; 2008 Jun; 58(6):396-401. PubMed ID: 18477220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
    Sreenan JJ; Prayson RA
    Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular gliosarcoma with dual sarcomatous differentiation: A unique case.
    Poyuran R; Bn N; Reddy YVK; Savardekar AR
    Neuropathology; 2017 Aug; 37(4):346-350. PubMed ID: 28261869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliosarcoma with osteosarcomatous features: a short illustrated review.
    Charfi S; Ayadi L; Khabir A; Daoud E; Kallel R; Kharrat O; Mnif Z; Boudawara Z; Makni S; Boudawara T
    Acta Neurochir (Wien); 2009 Jul; 151(7):809-13; discussion 813. PubMed ID: 19399365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gliosarcoma with liposarcomatous component, bone infiltration and extracranial growth.
    Borota OC; Scheie D; Bjerkhagen B; Jacobsen EA; Skullerud K
    Clin Neuropathol; 2006; 25(4):200-3. PubMed ID: 16866302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential recurrence of a sarcomatous component of a gliosarcoma after boron neutron capture therapy: case report.
    Miyatake S; Kuwabara H; Kajimoto Y; Kawabata S; Yokoyama K; Doi A; Tsuji M; Mori H; Ono K; Kuroiwa T
    J Neurooncol; 2006 Jan; 76(2):143-7. PubMed ID: 16234987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliosarcoma with alveolar rhabdomyosarcoma-like component: report of a case with a hitherto undescribed sarcomatous component.
    Svajdler M; Rychlý B; Gajdoš M; Pataky F; Fröhlichová L; Perry A
    Cesk Patol; 2012 Oct; 48(4):210-4. PubMed ID: 23121030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pediatric gliosarcoma with fibrosarcomatous differentiation: report of a rare case.
    Ravisankar S; Chander RV; Devadoss PK
    Indian J Pathol Microbiol; 2012; 55(4):521-4. PubMed ID: 23455794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic features of primary and postirradiation cerebral gliosarcoma.
    Perry JR; Ang LC; Bilbao JM; Muller PJ
    Cancer; 1995 Jun; 75(12):2910-8. PubMed ID: 7773942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metachronous cardiac and cerebral sarcomas: case report with focus on molecular findings and review of the literature.
    Guerriero A; Giovenali P; La Starza R; Mecucci C; Montesi G; Pasquino S; Pierini T; Ragni T; Sidoni A
    Hum Pathol; 2015 Mar; 46(3):482-7. PubMed ID: 25586016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoma arising as a distinct nodule within glioblastoma: a morphological and molecular perspective on gliosarcoma.
    Jimenez C; Powers M; Parsa AT; Glastonbury C; Hagenkord JM; Tihan T
    J Neurooncol; 2011 Nov; 105(2):317-23. PubMed ID: 21533839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological characteristics and outcomes of Gliosarcoma.
    Hashmi FA; Salim A; Shamim MS; Bari ME
    J Pak Med Assoc; 2018 Aug; 68(8):1273-1275. PubMed ID: 30108403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics.
    Cachia D; Kamiya-Matsuoka C; Mandel JJ; Olar A; Cykowski MD; Armstrong TS; Fuller GN; Gilbert MR; De Groot JF
    J Neurooncol; 2015 Nov; 125(2):401-10. PubMed ID: 26354773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma.
    Kiang KM; Chan AA; Leung GK
    BMC Cancer; 2021 Mar; 21(1):265. PubMed ID: 33706745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortactin, fascin and survivin expression associated with clinicopathological parameters in brain gliosarcoma.
    Chen JH; Chen KY; Ma HI; Yu CP; Nieh S; Lee HS; Jin JS
    Chin J Physiol; 2010 Aug; 53(4):234-44. PubMed ID: 21793333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-focal gliosarcoma: a case report and review of the literature.
    Pakos EE; Goussia AC; Zina VP; Pitouli EJ; Tsekeris PG
    J Neurooncol; 2005 Sep; 74(3):301-4. PubMed ID: 16086111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gliosarcoma with osteosarcomatous component: A case report and short review illustration.
    Chen Y; Zhou S; Zhou X; Dai X; Wang L; Chen P; Zhao S; Shi C; Xiao S; Dong J
    Pathol Res Pract; 2022 Apr; 232():153837. PubMed ID: 35278815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histopathological and immunohistochemical studies on gliosarcoma].
    Zhao L; Lu D; Xu Q
    Zhonghua Bing Li Xue Za Zhi; 1996 Feb; 25(1):10-2. PubMed ID: 8762432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.